Skip to main content

Analysis of Survival of Prostate Cancer Patients in Japan and the USA

  • Chapter
Prostate Cancer and Bone Metastasis

Abstract

The prognosis of U.S.A. patients with prostate cancer based on reports from the American College of Surgeons and Roswell Park Cancer Institute was compared with that of Japanese in Nagasaki and Gunma. There was more than a 10% difference in survival rate between the two countries. Several clinical parameters were analyzed to determine the basis for this difference. In general, stage distribution, metastatic sites, bone pain and alkaline phosphatase in the USA patients with Stage D disease were more severe than in the Japanese patients. Moreover the prostate cancer death rate in the USA was higher than that in Japan. However, only the distribution of pathological grade in the USA was better than that in Japan. From these results, it is difficult to conclude that prostate cancer in the USA is more aggressive than in Japan. The possibility of selection bias in these studies is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parkin D.M., Laara E. and Muir C.S., Estimates of the worldwide frequency of sixteen major cancers in 1980, Int. J. Cancer 41:184–197 (1988).

    Article  PubMed  CAS  Google Scholar 

  2. Waterhouse J.A.H., Muir C.S., Shanmugaratnam K. and Powell J., Cancer incidence in five continents, IARC Sci. Pub., Vol. IV, 42 (1982).

    Google Scholar 

  3. Akazaki K. and Stemmermann G.N., Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii, J. Natl. Cancer Inst. 50:1137–1144 (1973)

    PubMed  CAS  Google Scholar 

  4. Yatani R., Chigusa I., Akazaki K., Stemmermann G.N., et al, Geographic pathology of latent prostatic carcinoma, Int. J. Cancer 29:611–616 (1982).

    Article  PubMed  CAS  Google Scholar 

  5. Murphy G.P., Saroff J., Joiner J. and Gaeta J., Prostatic carcinoma, NY State J. of Med. 75:1663–1669 (1975).

    CAS  Google Scholar 

  6. Slack N.H., Brady M.F. and Murphy G.P., Prostatic carcinoma, NY State J. of Med. 83:699–705 (1983).

    CAS  Google Scholar 

  7. Slack N.H., Lane W.W., Priore R.L. and Murphy G.P., Prostatic cancer, Urology 27(3):205–213 (1986).

    Article  PubMed  CAS  Google Scholar 

  8. Murphy G.P., Natarajan N., Pontes J.E., Schmitz R.L., Smart C.R., Schmidt J.D. and Mettlin C., The national survey of prostate cancer in the United States by the American College of Surgeons, J. Urol. 127:928–934 (1982).

    PubMed  CAS  Google Scholar 

  9. Mettlin C., Natarajan N. and Murphy G.P., Recent patterns of care of prostate cancer patients in the United States: Results from the surveys of the American College of Surgeons Commission on Cancer, Int. Advances in Surgical Oncol. 5:277–321 (1982).

    CAS  Google Scholar 

  10. Soloway M.S., Hardeman S.W., Hickey D., Raymond J., Todd B., Soloway S. and Moinuddin M., Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan, Cancer 61:195–202 (1988)

    Article  PubMed  CAS  Google Scholar 

  11. Imai K., Suzuki T., Hayashi M., Nakazawa Y., Nakata S., Yamanaka H., Kitaura K., Tomaru Y., Miki M., Kato N., Sato J., Takahashi H., Koya A., Kurihara H., Makino T., Ebihara., Shinozaki T., Kurosawa I., Matsushita I. and Takeuchi H., Prognostic factor for prostate cancer, Jpn I. Urol. 81(8):1217–1224 (1990).

    CAS  Google Scholar 

  12. Imai K., Onuki T., Okabe K., Kurita M., Kurokawa K., Yamanaka H. and Tomaru Y., Prognostic factor for the patients with bone metastasis of prostate cancer, proceeding of the first workshop on prostate cancer 1990:54–57 (1990).

    Google Scholar 

  13. Imai K., Zinbo S., Shimizu K., Yamanaka H., Kumasaka F. and Sato Z., Clinical characteristics of prostatic cancer detected by mass screening, The Prostate 12:199–207 (1988).

    Article  PubMed  CAS  Google Scholar 

  14. Kumamoto Y., Tsukamoto T., Umehara T., et al, Clinical studies endocrine therapy for prostatic carcinoma (2): Prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses on causes of death and side effect of endocrine therapy, Ada. Urol. Jpn., 36:285–293 (1990).

    CAS  Google Scholar 

  15. The Veterans Administration Cooperative Urological Research: Treatment and survival of patients with cancer of prostate, Surg. Gynecol. Obstet. 124:1011–1017 (1969).

    Google Scholar 

  16. Eisenberger M.A., Chemotherapy for prostate carcinoma, NCI Monographs 7:151–163 (1988).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Imai, K. et al. (1992). Analysis of Survival of Prostate Cancer Patients in Japan and the USA. In: Karr, J.P., Yamanaka, H. (eds) Prostate Cancer and Bone Metastasis. Advances in Experimental Medicine and Biology, vol 324. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3398-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3398-6_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6501-3

  • Online ISBN: 978-1-4615-3398-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics